Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ishmael S, Hassen"'
Autor:
Tigist W. Leulseged, Degu G. Alemahu, Ishmael S. Hassen, Endalkachew H. Maru, Wuletaw C. Zewde, Negat W. Chamiso, Kalkidan T. Yegele, Daniel S. Abebe, Firaol M. Abdi, Etsegenet Y. Minyelshewa, Tegenu G. Gerbi, Helen T. Hagos
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Studies show that having some symptoms seems to be associated with more severe disease and poor prognosis. Therefore, knowing who is more susceptible to symptomatic COVID-19 disease is important to provide targeted preventive and
Externí odkaz:
https://doaj.org/article/83c02459a97046738ab8dfd00dc480b7
Autor:
Tigist W Leulseged, Kindalem G Abebe, Ishmael S Hassen, Endalkachew H Maru, Wuletaw C Zewde, Negat W Chamiso, Kalkidan T Yegele, Abdi B Bayisa, Dagne F Siyoum, Mesay G Edo, Edmialem G Mesfin, Meskerem N Derejie, Helina K Shiferaw
Publikováno v:
PLoS ONE, Vol 17, Iss 1, p e0262896 (2022)
BackgroundThe COVID-19 pandemic started a little later in Ethiopia than the rest of the world and most of the initial cases were reported to have a milder disease course and a favorable outcome. This changed as the disease spread into the population
Externí odkaz:
https://doaj.org/article/6a78f1e51e014dc2ab381802bd757ccc
Autor:
Tigist W Leulseged, Ishmael S Hassen, Birhanu T Ayele, Yakob G Tsegay, Daniel S Abebe, Mesay G Edo, Endalkachew H Maru, Wuletaw C Zewde, Lydia K Naylor, Dejene F Semane, Menayit T Dresse, Bereket B Tezera
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0246087 (2021)
AimTo identify laboratory biomarkers that predict disease severity and outcome among COVID-19 patients admitted to the Millennium COVID-19 Care Center in Ethiopia.MethodsA retrospective cohort study was conducted among 429 COVID-19 patients who were
Externí odkaz:
https://doaj.org/article/ebcc0bdf111346dba71c214a30300a55
Autor:
Tigist W. Leulseged, Ishmael S. Hassen, Endalkachew H. Maru, Wuletaw C. Zewsde, Negat W. Chamiso, Abdi B. Bayisa, Daniel S. Abebe, Birhanu T. Ayele, Kalkidan T. Yegle, Mesay G. Edo, Eyosyas K. Gurara, Dereje D. Damete, Yared A. Tolera
Publikováno v:
PLoS ONE, Vol 16, Iss 11 (2021)
Background The COVID-19 pandemic seems to have a different picture in Africa; the first case was identified in the continent after it had already caused a significant loss to the rest of the world and the reported number of cases and mortality rate h
Externí odkaz:
https://doaj.org/article/7cca4f7d2a2c4af3a65e2b4dcf942509
Autor:
Tegenu G. Gerbi, Degu G. Alemahu, Tigist W. Leulseged, Etsegenet Y Minyelshewa, Ishmael S. Hassen, Wuletaw C. Zewde, Negat W Chamiso, Firaol M. Abdi, Kalkidan T. Yegele, Helen T. Hagos, Endalkachew H. Maru, Daniel S. Abebe
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-7 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Studies show that having some symptoms seems to be associated with more severe disease and poor prognosis. Therefore, knowing who is more susceptible to symptomatic COVID-19 disease is important to provide targeted preventive and managemen
Autor:
Endalkachew H. Maru, Zerihun A. Terefe, Wuletaw C. Zewde, Fiseha E. Mihretu, Naol A. Baruda, Mesay G. Edo, Lydia K. Naylor, Henok N. Desalegn, Nardos T. Kidane, Yakob G. Tsegay, Tigist W. Leulseged, Ishmael S. Hassen, Dawit A. Abebe
Background The role of drugs that inhibit ACE2 expression on COVID-19 disease severity, progression and outcome has been debatable with studies reporting contradictory findings. So far, there is no such study conducted in Africa. Having clarity on th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2eeb497d65d9629a342f7a57b76d87f
https://doi.org/10.21203/rs.3.rs-724357/v1
https://doi.org/10.21203/rs.3.rs-724357/v1
Autor:
Abdi Bekele Banegyisa, Wondmagegn Genaneh Shiferaw, Ishmael S. Hassen, Teketel T. Admasu, Wuletaw C. Zewde, Endalkachew H. Maru, Oli Seyoum Tefera, Negat W Chamiso, Tariku B. Jagema, Daniel S. Abebe, Tigist W. Leulseged, Mesfin Abebe Gezahegn
Publikováno v:
The Pan African Medical Journal
Pan African Medical Journal; Vol. 38 No. 1 (2021)
Pan African Medical Journal; Vol. 38 No. 1 (2021)
BackgroundAs the number of new cases and death due to COVID-19 is increasing, understanding the characteristics of severe COVID-19 patients and identifying characteristics that lead to death is a key to make an informed decision. In Ethiopia, as of S
Autor:
Yared A Tolera, Negat W Chamiso, Mesay G. Edo, Dereje D Damete, Tigist W. Leulseged, Daniel S. Abebe, Endalkachew H. Maru, Abdi B. Bayisa, Eyosyas K Gurara, Birhanu T. Ayele, Wuletaw C Zewsde, Kalkidan T Yegle, Ishmael S. Hassen
Publikováno v:
PLoS ONE, Vol 16, Iss 11, p e0259454 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 11 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 11 (2021)
Background The COVID-19 pandemic seems to have a different picture in Africa; the first case was identified in the continent after it had already caused a significant loss to the rest of the world and the reported number of cases and mortality rate h
Autor:
Ishmael S. Hassen, Helen T. Hagos, Nigat W. Chamesew, Tegenu G. Gerbi, Etsegenet Y. Menyelshewa, Firaol M. Abdi, Kalkidan T. Yegele, Wuletaw C. Zewde, Endalkachew H. Maru, Tigist W. Leulseged, Degu G. Alemahu, Daniel S. Abebe
Background: Studies show that having some symptoms seems to be associated with more severe disease and poor prognosis. Therefore, knowing who is more susceptible to symptomatic COVID-19 disease is important to provide targeted preventive and manageme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::781bc6bd1e4cac505f2c687d7cbeaca7
https://doi.org/10.21203/rs.3.rs-136541/v1
https://doi.org/10.21203/rs.3.rs-136541/v1
Autor:
Tigist W, Leulseged, Ishmael S, Hassen, Mesay G, Edo, Daniel S, Abebe, Endalkachew H, Maru, Wuletaw C, Zewde, Negat W, Chamiso, Tariku B, Jagema
Publikováno v:
Ethiopian Journal of Health Sciences
Background With the rising number of new cases of COVID-19, understanding the oxygen requirement of severe patients assists in identifying at risk groups and in making an informed decision on building hospitals capacity in terms of oxygen facility ar